On ECHEMI
Home > Drugs > Shaanxi Dunsi Pharmaceutical Co., Ltd.
Shaanxi Dunsi Pharmaceutical Co., Ltd.
  • Founded in:

    2016-08-12
  • Country:

    China China
  • Address:

    Xi'an Fengjing Industrial Park Standardized Factory Phase I Construction Area
  • Tax NO.:

    91610125MA6TYKEJ97
  • Registered Funds:

    96 million yuan
  • Website:

  • Email:

Related Drugs
Potassium Chloride Injection
Potassium chloride
Name Description Content CAS NO. Registered Holders
Potassium chloride

Potassium is the main cation in cells, with a concentration of 150-160 mmol/L, while the main cation outside cells is sodium ions, and the serum potassium concentration is only 3.5-5.0 mmol/L. The body mainly relies on Na+-K+ ATPase on the cell membrane to maintain the difference in K+ and Na+ concentrations inside and outside cells. The acid-base balance in the body has an impact on potassium metabolism. For example, when acidosis occurs, H+ enters the cell. In order to maintain the potential difference inside and outside the cell, K+ is released outside the cell, causing or aggravating hyperkalemia. Metabolic disorders can also affect acid-base balance. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

More

Potassium is the main cation in cells, with a concentration of 150-160 mmol/L, while the main cation outside cells is sodium ions, and the serum potassium concentration is only 3.5-5.0 mmol/L. The body mainly relies on Na+-K+ ATPase on the cell membrane to maintain the difference in K+ and Na+ concentrations inside and outside cells. The acid-base balance in the body has an impact on potassium metabolism. For example, when acidosis occurs, H+ enters the cell. In order to maintain the potential difference inside and outside the cell, K+ is released outside the cell, causing or aggravating hyperkalemia. Metabolic disorders can also affect acid-base balance. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

7447-40-7 39
Potassium Chloride Injection
Potassium chloride
Name Description Content CAS NO. Registered Holders
Potassium chloride

Potassium is the main cation in cells, with a concentration of 150-160 mmol/L, while the main cation outside cells is sodium ions, and the serum potassium concentration is only 3.5-5.0 mmol/L. The body mainly relies on Na+-K+ ATPase on the cell membrane to maintain the difference in K+ and Na+ concentrations inside and outside cells. The acid-base balance in the body has an impact on potassium metabolism. For example, when acidosis occurs, H+ enters the cell. In order to maintain the potential difference inside and outside the cell, K+ is released outside the cell, causing or aggravating hyperkalemia. Metabolic disorders can also affect acid-base balance. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

More

Potassium is the main cation in cells, with a concentration of 150-160 mmol/L, while the main cation outside cells is sodium ions, and the serum potassium concentration is only 3.5-5.0 mmol/L. The body mainly relies on Na+-K+ ATPase on the cell membrane to maintain the difference in K+ and Na+ concentrations inside and outside cells. The acid-base balance in the body has an impact on potassium metabolism. For example, when acidosis occurs, H+ enters the cell. In order to maintain the potential difference inside and outside the cell, K+ is released outside the cell, causing or aggravating hyperkalemia. Metabolic disorders can also affect acid-base balance. The normal potassium ion concentration and concentration difference inside and outside cells are closely related to certain functions of cells, such as carbohydrate metabolism, glycogen storage and protein metabolism, excitability and conductivity of nerves and muscles including myocardium, etc.

7447-40-7 39
Furosemide Injection
The main ingredient of this product: furosemide. Chemical name: 2-[(2-furanmethyl)amino]-5-(aminosulfonyl)-4-chlorobenzoic acid. Molecular formula: C12H11ClN2O5S Molecular weight: 330.75 Excipients: sodium chloride, sodium hydroxide, water for injection
Name Description Content CAS NO. Registered Holders
Furosemide

1. Effect on water and electrolyte excretion: It can increase the excretion of water, sodium, chloride, potassium, calcium, magnesium, phosphorus, etc. It mainly inhibits the active reabsorption of NaCl by the thick-walled segment of the renal tubular loop, reduces the osmotic pressure gradient difference of the medullary interstitial fluid, and leads to increased excretion of water, Na+, and Cl-; promotes increased Na+-K+ and Na+-H+ exchange in the distal tubule, which increases the excretion of K+ and H+; inhibits the reabsorption of Ca2+ and Mg2+ by the loop of Henle and increases their excretion. Short-term medication can increase uric acid excretion, while long-term medication can cause hyperuricemia. 2. Effect on hemodynamics: Furosemide can inhibit the activity of prostaglandin degrading enzymes, increase the content of prostaglandin E2, and have a vasodilatory effect; dilate renal blood vessels, reduce renal vascular resistance, and increase renal blood flow; increase tubular fluid flow without reducing glomerular filtration rate; can dilate pulmonary capacitance veins, reduce pulmonary capillary permeability, reduce venous return, and reduce left ventricular end-diastolic pressure, which is helpful in the treatment of acute left heart failure and adult respiratory distress syndrome.

More

1. Effect on water and electrolyte excretion: It can increase the excretion of water, sodium, chloride, potassium, calcium, magnesium, phosphorus, etc. It mainly inhibits the active reabsorption of NaCl by the thick-walled segment of the renal tubular loop, reduces the osmotic pressure gradient difference of the medullary interstitial fluid, and leads to increased excretion of water, Na+, and Cl-; promotes increased Na+-K+ and Na+-H+ exchange in the distal tubule, which increases the excretion of K+ and H+; inhibits the reabsorption of Ca2+ and Mg2+ by the loop of Henle and increases their excretion. Short-term medication can increase uric acid excretion, while long-term medication can cause hyperuricemia. 2. Effect on hemodynamics: Furosemide can inhibit the activity of prostaglandin degrading enzymes, increase the content of prostaglandin E2, and have a vasodilatory effect; dilate renal blood vessels, reduce renal vascular resistance, and increase renal blood flow; increase tubular fluid flow without reducing glomerular filtration rate; can dilate pulmonary capacitance veins, reduce pulmonary capillary permeability, reduce venous return, and reduce left ventricular end-diastolic pressure, which is helpful in the treatment of acute left heart failure and adult respiratory distress syndrome.

54-31-9 49
Cefoperazone Sodium and Sulbactam Sodium for Injection
This product is a compound preparation, and its components are: each vial contains 0.5g of cefoperazone sodium calculated as cefoperazone and 0.5g of sulbactam sodium calculated as sulbactam.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

The third generation cephalosporins achieve their bactericidal effect by inhibiting the biosynthesis of the cell wall of sensitive bacteria.

More

The third generation cephalosporins achieve their bactericidal effect by inhibiting the biosynthesis of the cell wall of sensitive bacteria.

0.5g 62893-20-3 23
Sulbactam sodium

It has an irreversible inhibitory effect on most important β-lactamases produced by strains resistant to β-lactam antibiotics, can protect β-lactam antibiotics from hydrolytic destruction by β-lactamases of resistant bacteria, and has a synergistic effect when used in combination with cefoperazone.

More

It has an irreversible inhibitory effect on most important β-lactamases produced by strains resistant to β-lactam antibiotics, can protect β-lactam antibiotics from hydrolytic destruction by β-lactamases of resistant bacteria, and has a synergistic effect when used in combination with cefoperazone.

0.5g 69388-84-7 30
Cefoperazone Sodium and Sulbactam Sodium for Injection (2:1)
This product is a sterile powder of cefoperazone sodium and sulbactam sodium (2:1) uniformly mixed. Chemical name: Cefoperazone sodium is (6R, 7R)-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarbonylamino)-2-p-hydroxyphenyl-acetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt. Sulbactam sodium is (2S, 5R)-3,3-dimethyl-7oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate sodium-4,4 dioxide sodium salt.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. It is highly sensitive to Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis. It also has good effect on all groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strain). It has good effect on most Gram-positive anaerobes and some Gram-negative anaerobes. It mainly inhibits the synthesis of bacterial cell walls.

More

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. It is highly sensitive to Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis. It also has good effect on all groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strain). It has good effect on most Gram-positive anaerobes and some Gram-negative anaerobes. It mainly inhibits the synthesis of bacterial cell walls.

62893-20-3 23
Sulbactam sodium

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

More

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

69388-84-7 30
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.